Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis ; volume:14 ; number:1 ; day:15 ; month:2 ; year:2014 ; pages:1-7 ; date:12.2014
BMC pulmonary medicine ; 14, Heft 1 (15.2.2014), 1-7, 12.2014
- Creator
-
DiMango, Emily
- Contributor
-
Walker, Patricia
Keating, Claire
Berdella, Maria
Robinson, Newell
Langfelder-Schwind, Elinor
Levy, Diane
Liu, Xinhua
SpringerLink (Online service)
- DOI
-
10.1186/1471-2466-14-21
- URN
-
urn:nbn:de:1111-201608164450
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- DiMango, Emily
- Walker, Patricia
- Keating, Claire
- Berdella, Maria
- Robinson, Newell
- Langfelder-Schwind, Elinor
- Levy, Diane
- Liu, Xinhua
- SpringerLink (Online service)
Other Objects (12)
BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis
Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations
Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations
Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis
Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization
Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis
Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations
Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function
A 2-year-old girl with co-inherited cystic fibrosis and sickle cell-β+ thalassemia presenting with recurrent vaso-occlusive events during cystic fibrosis pulmonary exacerbations: a case report
Pulmonary aspiration in preschool children with cystic fibrosis
Flexible semiparametric joint modeling: an application to estimate individual lung function decline and risk of pulmonary exacerbations in cystic fibrosis
BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis
Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations
Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations
Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis
Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization
Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis
Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations
Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function
A 2-year-old girl with co-inherited cystic fibrosis and sickle cell-β+ thalassemia presenting with recurrent vaso-occlusive events during cystic fibrosis pulmonary exacerbations: a case report
Pulmonary aspiration in preschool children with cystic fibrosis
Flexible semiparametric joint modeling: an application to estimate individual lung function decline and risk of pulmonary exacerbations in cystic fibrosis
BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis
Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations
Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations
Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis
Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization
Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis
Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations
Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function
A 2-year-old girl with co-inherited cystic fibrosis and sickle cell-β+ thalassemia presenting with recurrent vaso-occlusive events during cystic fibrosis pulmonary exacerbations: a case report
Pulmonary aspiration in preschool children with cystic fibrosis